An Unholy Trinity?

The "big three" journals, Nature, Science, and Cell, undoubtedly have some say in the development and perception of science. But what exactly is their impact? How long-lasting is it? Is it helpful or damaging? The story on page 59 of this issue considers how competition among these journals for high-profile breakthroughs may harm the scientific process, and another on page 76 profiles one of the architects of the current state of affairs. Is it now time, in the best interests of science, to d

Written byRichard Gallagher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The "big three" journals, Nature, Science, and Cell, undoubtedly have some say in the development and perception of science. But what exactly is their impact? How long-lasting is it? Is it helpful or damaging?

The story on page 59 of this issue considers how competition among these journals for high-profile breakthroughs may harm the scientific process, and another on page 76 profiles one of the architects of the current state of affairs. Is it now time, in the best interests of science, to dismantle the hegemony? Here are my thoughts, but bear in mind that having spent the past decade at Science and Nature, I may be institutionalized.

Among the charges brought in our stories are that too much power is concentrated in the hands of a few individuals; that these individuals, namely the editors, don't know what they are doing; or that they do know what they are doing, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies